EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

L-Fucose Suppresses Lipid Accumulation via the AMPK Pathway in 3T3-L1 Adipocytes

Tomohiko Nakao, Shiro Otaki, Yuri Kominami, Soichi Watanabe, Miho Ito, Teruki Aizawa, Yusuke Akahori, Hideki Ushio

Nutrients · 2023

DOI: 10.3390/nu15030503 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Tomohiko Nakao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Fucose. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, Japan Society for the Promotion of Science, Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

L-fucose (Fuc), a monosaccharide with different biological functions in various organisms, exhibits potent anti-obesity effects in obese mice. However, the mechanisms underlying its anti-obesity effects remain largely unknown. In this study, we aimed to investigate the effects of Fuc on lipid metabolism and insulin signaling in 3T3-L1 adipocytes. We found that Fuc treatment suppressed lipid accumulation during adipocyte differentiation. Additionally, Fuc treatment enhanced the phosphorylation of AMP-activated kinase (AMPK) and its downstream pathways, responsible for the regulation of fatty acid oxidation and lipolysis. Furthermore, Fuc-induced activation of the AMPK pathway was diminished by the AMPK inhibitor Compound C, and Fuc treatment considerably promoted glucose uptake via Akt activation in an insulin-resistant state. These findings provide a basis for elucidating the mechanism underlying the anti-obesity effect of Fuc, which may, in the future, be considered as a therapeutic compound for treating obesity and related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesFucoseMiceAnimals3T3-L1 CellsAdipocytesInsulinObesityLipidsAdipogenesis

Stichwörter der Autor:innen

AMPKL-fucoseanti-obesityinsulin signalinglipolysis

Substanzen

AMP-Activated Protein KinasesFucoseInsulinLipids

Autor:innen und Institutionen

  • Department of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, University of Tokyo, Tokyo 113-8657, Japan.
  • Yaizu Suisankagaku Industry Co., Ltd., 5-8-13 Kogawa-shimmachi, Yaizu, Shizuoka 425-8570, Japan.

Förderung

  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science
  • Adaptable and Seamless Technology transfer Program through Target-driven R&D (A-STEP)
  • Grant-in-Aid for Scientific Research (A)

Zitieren

APA

Nakao, T., Otaki, S., Kominami, Y., Watanabe, S., Ito, M., Aizawa, T., Akahori, Y., & Ushio, H. (2023). L-Fucose Suppresses Lipid Accumulation via the AMPK Pathway in 3T3-L1 Adipocytes. Nutrients. https://doi.org/10.3390/nu15030503

Vancouver

Nakao T, Otaki S, Kominami Y, Watanabe S, Ito M, Aizawa T, et al. L-Fucose Suppresses Lipid Accumulation via the AMPK Pathway in 3T3-L1 Adipocytes. Nutrients. 2023. doi:10.3390/nu15030503

BibTeX
@article{Nakao2023,
  author = {Nakao, Tomohiko and Otaki, Shiro and Kominami, Yuri and Watanabe, Soichi and Ito, Miho and Aizawa, Teruki and Akahori, Yusuke and Ushio, Hideki},
  title = {L-Fucose Suppresses Lipid Accumulation via the AMPK Pathway in 3T3-L1 Adipocytes},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15030503}
}
Kostenlos starten →